Genome-wide Association Study Identifies Genetic Variants Associated With Early and Sustained Response to (Pegylated) Interferon in Chronic Hepatitis B Patients: The GIANT-B Study


Brouwer W. P., Chan H. L. Y., Lampertico P., Hou J., Tangkijvanich P., Reesink H. W., ...Daha Fazla

CLINICAL INFECTIOUS DISEASES, cilt.69, sa.11, ss.1969-1979, 2019 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 69 Sayı: 11
  • Basım Tarihi: 2019
  • Doi Numarası: 10.1093/cid/ciz084
  • Dergi Adı: CLINICAL INFECTIOUS DISEASES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1969-1979
  • Eskişehir Osmangazi Üniversitesi Adresli: Evet

Özet

Background. (Pegylated) Interferon ([Peg]IFN) therapy leads to response in a minority of chronic hepatitis B (CHB) patients. Host genetic determinants of response are therefore in demand.